J&J Compliance Consulting Inc.

Facebook Twitter Instagram Linkedin
Get A Quote

FDA-PMTA Application

Expert PMTA regulatory support services

We guide tobacco manufacturers through PMTA preparation, submission, and FDA review using proven regulatory strategies and scientific compliance expertise.
Get a quote

Call for Appoinment

+ 1 949 390 5684

99%

Satisfy client

Years of Experience
0 +

PMTA Introduction

What is Premarket of a Tobacco Application ?

A Premarket Tobacco Product Application (PMTA) is required before any new tobacco product can be legally marketed in the United States. The FDA reviews PMTAs to determine whether a product is appropriate for the protection of public health, based on scientific evidence and population impact.

Since the first PMTA authorization in 2015, FDA review standards have become increasingly rigorous. A complete, well-structured submission is critical to approval success.

  • FDA review required before marketing
  • Ensures public health protection standards
  • Mandatory for new tobacco products
Schedule a Free Consultation

Overview of PMTAs

Guide to premarket tobacco product applications (PMTA)

Any person can submit a Premarket Tobacco Product Application (PMTA) for any seeking an FDA marketing order under section 910(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act.
Population Risks

Population Risks

FDA evaluates overall risks and benefits to users and nonusers before authorizing new products.

01/
Current Users

Current Users

FDA considers if current tobacco users are likely to stop using products with availability.

02/
Non-Users

Non-Users

FDA assesses whether non-users may start using tobacco if the new product launches.

03/
Public Health

Public Health

Scientific data must demonstrate the product is appropriate for protecting public health nationwide.

04/
  • 30+ years combined regulatory expertise
  • Successfully submitted hundreds PMTA applications
  • FDA approvals for new tobacco products
  • Comprehensive consumer perception studies completed
  • Expertise in HPHC reporting compliance

Our Achievements

Key milestones andachievements

Years Of Research
0 +
Satisfaction Rate
0 %
Medical Partner
0 +

Process ​

PMTA Review Process ​

The PMTA review process includes pre-submission meetings, acceptance review, filing review, substantive scientific evaluation, and post-market reporting compliance.

A voluntary formal meeting between the applicant and FDA to discuss a planned PMTA submission for a tobacco product.

  • Meeting granted letter or
  • Meeting denial letter
  • Meeting minutes letter (if the meeting is granted and held)
An administrative review that ensures the product falls under Center for Tobacco Products jurisdiction and confirms that the statutory and regulatory requirements of an application are met based upon Section 910 of the FD&C Act and the criteria set forth in § 1114.27(a)(1).
  • Acceptance letter or
  • Refuse to accept (RTA) letter
A threshold determination of whether the application contains sufficient information to permit a substantive review. FDA may refuse to file a PMTA if any of the criteria in § 1114.27(b)(1) apply.
  • Filing letter or
  • Refuse to file (RTF) letter
FDA evaluation of the scientific information and data in an application, as well as recommendations from the Tobacco Product Scientific Advisory Committee (TPSAC), if the application was referred.
  • Deficiency letter: Additional information is needed to complete a scientific review. The letter will specify the number of days an applicant has to respond.
  • Environmental information request letter: FDA made a scientific decision to issue a marketing granted order; however, the applicant is required to provide information for environmental considerations before a marketing granted order can be issued.

Clinical study requires meticulous planning and careful execution. Failure to adhere to well-thought study protocol/regiment, may lead to a waste of resources

  • Marketing granted order letter or
  • Marketing denial order letter
Requires applicants to establish and maintain records and make reports that FDA requires as necessary to determine or facilitate a determination of whether there may be grounds to withdraw or temporarily suspend a marketing granted order. Post-market reporting requirements for all products that receive a marketing granted order are set forth in § 1114.41 and FDA may require additional reporting under the terms of a marketing granted order.

Submit PMTA

How to Submit a PMTA

Follow FDA guidelines carefully. Request IAM account, prepare electronically, submit via CTP Portal, or request waiver if needed.

Request IAM Account

Apply for an IAM account if your company does not already have one, enabling secure access to FDA systems.

Prepare Electronically

Complete your PMTA application using the eSubmitter software and the CTP Transmittal Form template for accurate submission.

Submit Online

Once prepared, submit your PMTA online via the CTP Portal for FDA review and consideration.

Step-by-Step Guide to Successful PMTA Submission Process

Get Expert Help

Ready to Navigate the PMTA Process Confidently?

JJCC Group’s regulatory consultants help tobacco product manufacturers prepare, submit, review, and defend successful PMTAs efficiently and effectively.
Schedule Consultation

How to Prepare

Preparation of the Premarket Tobacco Product Applications (PMTAs)​

A PMTA must include complete product data, health risk reports, labeling, manufacturing details, compliance evidence, and FDA-required documentation.

Under the FD&C Act, a PMTA includes (per section 910(b)(1))

Applicants must provide full reports of known health risks, detailed statements of components and ingredients, descriptions of manufacturing methods and controls, reference any applicable product standards with justification, and include required product samples and proposed labeling specimens.

FDA mandates PMTA include specific sections under 1114.7.

General information, descriptive information, product samples, labeling and marketing plans, compliance statement with 21 CFR part 25, summary, product formulation, manufacturing, health risk investigations, population effect, and certification statement included in PMTA submission.

Comply with PMTA format requirements per 21 CFR.

Your PMTA submission must include all required FDA forms, a comprehensive index, table of contents, clear organization, English language documents, accurate supporting data, proper labeling, attachments, references, and be submitted electronically unless a waiver is granted by the FDA.

Submission Compliance

Your PMTA submission must include all required FDA forms, a comprehensive index listing all files and data, a clear table of contents, well-organized and legible documentation, properly translated English language documents if needed, and must be submitted electronically in a format the FDA can process, read, review, and archive.

Best Compliance with 5 Star

99% Happy Clients

Testimonial

Trusted PMTA Regulatory Experts

Hear from tobacco manufacturers who successfully navigated the PMTA process with JJCC Group’s expert regulatory guidance.

Their PMTA expertise, documentation accuracy, and FDA communication support helped us avoid delays and regulatory setbacks.

Sarah Bennett OWNER

JJCC simplified a complex PMTA process, delivering structured guidance, strong scientific support, and reliable regulatory strategy.

Bts Ashik OWNER

Working with JJCC Group gave us confidence, clarity, and a trusted partner throughout the entire PMTA approval journey process.

Shadin De Manager

Faqs

Frequently asked questions

Our PMTA FAQs help manufacturers understand FDA expectations, documentation needs, scientific requirements, review timelines, and post-submission obligations, ensuring confidence throughout the PMTA process and reducing regulatory uncertainty during product approval.
Contact now
What is a PMTA?
A PMTA is an FDA application required to demonstrate a tobacco product protects public health before legal U.S. marketing approval.
Any manufacturer seeking to market new tobacco or vape products in the United States must submit a PMTA.
FDA requires scientific, toxicological, manufacturing, and population impact data proving product safety and public health benefit.
PMTA review timelines vary, depending on application completeness, scientific complexity, and FDA review workload and requests.
Incomplete data, poor organization, missing studies, or failure to demonstrate public health protection may lead to denial.
Scroll to Top